BuzzFeed CEO terminates RNC ad deal over Donald Trump, calling him 'hazardous to our health'
BuzzFeed will renege on an ad deal with the Republican National Committee because of the nature of Donald Trump's candidacy, BuzzFeed CEO Jonah Peretti announced Monday morning. BuzzFeed had signed an advertising agreement with the RNC in April, before Trump became the Republican Party's presumptive nominee. Peretti said that while BuzzFeed does not "expect to agree with the positions ... of all our advertisers," Trump's controversial statements — such as his suggestion to ban Muslim immigration or his comments toward women and immigrants — have made it necessary to "turn away revenue" rather than feature advertisements for the candidate.
"The Trump campaign is directly opposed to the freedoms of our employees in the United States and around the world," Peretti wrote in an email to staff. "We don't run cigarette ads because they are hazardous to our health, and we won't accept Trump ads for the exact same reason." BuzzFeed editor-in-chief Ben Smith elaborated that the decision was based in business concerns, noting that editorial decision-making regarding the election would not be affected by Peretti's announcement.
Politico reports that forfeiting the ad buy will cost BuzzFeed $1.3 million. Read Peretti's full statement at BuzzFeed News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kimberly Alters is the news editor at TheWeek.com. She is a graduate of the Medill School of Journalism at Northwestern University.
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
The week's best photos
In Pictures A cyclone's aftermath, a fearless leap, and more
By Anahi Valenzuela, The Week US Published
-
The Imaginary Institution of India: a 'compelling' exhibition
The Week Recommends 'Vibrant' show at the Barbican examines how political upheaval stimulated Indian art
By The Week UK Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published